Cardioloxía
Servicio
National and Kapodistrian University of Athens
Atenas, GreciaPublicacións en colaboración con investigadores/as de National and Kapodistrian University of Athens (29)
2024
2023
-
Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology
European Journal of Heart Failure, Vol. 25, Núm. 7, pp. 1025-1048
-
Care of patients with ST-elevation myocardial infarction: an international analysis of quality indicators in the acute coronary syndrome STEMI Registry of the EURObservational Research Programme and ACVC and EAPCI Associations of the European Society of Cardiology in 11 462 patients
European Heart Journal: Acute Cardiovascular Care, Vol. 12, Núm. 1, pp. 22-37
-
Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology
European Journal of Heart Failure, Vol. 25, Núm. 4, pp. 457-468
-
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
European Journal of Heart Failure, Vol. 25, Núm. 7, pp. 936-955
-
Rationale and design of the ESC Heart Failure III Registry – Implementation and discovery
European Journal of Heart Failure, Vol. 25, Núm. 12, pp. 2316-2330
2022
-
A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the ESC-HFA EORP Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 24, Núm. 2, pp. 335-350
-
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved
Nature Medicine, Vol. 28, Núm. 12, pp. 2512-2520
-
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial
The Lancet Diabetes and Endocrinology, Vol. 10, Núm. 1, pp. 35-45
2021
-
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
New England Journal of Medicine, Vol. 384, Núm. 2, pp. 105-116
-
Corrigendum to “European Resuscitation Council Guidelines 2021: Executive summary” [Resuscitation (2021) 1–60] (Resuscitation (2021) 161 (1–60), (S0300957221000551), (10.1016/j.resuscitation.2021.02.003))
Resuscitation
-
Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR
New England Journal of Medicine, Vol. 385, Núm. 23, pp. 2150-2160
-
Empagliflozin in heart failure with a preserved ejection fraction
New England Journal of Medicine, Vol. 385, Núm. 16, pp. 1451-1461
-
Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: The ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology
European Heart Journal, Vol. 42, Núm. 44, pp. 4536-4549
2020
-
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial
European Journal of Heart Failure, Vol. 22, Núm. 12, pp. 2383-2392
-
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials
European Journal of Heart Failure, Vol. 22, Núm. 11, pp. 2160-2171
-
Prevalence of risk of thrombosis and of bleeding and antithrombotic treatment in patients with heart failure
European Journal of Heart Failure
-
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 22, Núm. 1, pp. 92-102
2019
-
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1338-1352
-
Effects of serelaxin in patients with acute heart failure
New England Journal of Medicine, Vol. 381, Núm. 8, pp. 716-726